pancan.ai/Ask
what is known about trial:nct:NCT07252232
Understood asRecord NCT07252232View getStudy → table
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC) NCT07252232↗ Outcome: Ongoing
Computed from the knowledge API (getStudy); every record links to its source.